Eyad Abu‐Isa

1.1k citations
24 papers · 404 indexed · h-index 11
Topics
Breast Cancer Treatment Studies (6 papers)Prostate Cancer Diagnosis and Treatment (5 papers)Prostate Cancer Treatment and Research (5 papers)

In The Last Decade

Eyad Abu‐Isa

23 papers receiving 399 citations

Peers

Eyad Abu‐Isa
Comparison fields: 5 of 61
  • Pulmonary and Respiratory Medicine 204
  • Surgery 128
  • Oncology 126
  • Radiation 77
  • Radiology, Nuclear Medicine and Imaging 70
Replace Bok Ai Choo with:
Bok Ai Choo Singapore
J. Frew United Kingdom
Brent Chesson Australia
Caitlin A. Schonewolf United States
V. Kouloulias Greece
G.K. Rath India
Jesse N. Aronowitz United States
X. Sanz Spain
Indrani Bhattacharya United Kingdom
Ryan Neff United States
Eyad Abu‐Isa relative to Bok Ai Choo Singapore Bok Ai Choo's profile →
Citations per field
00.5×3.0×
Bok Ai Choo · 1×
Citations per year

Countries citing papers authored by Eyad Abu‐Isa

Since Specialization
Citations

This map shows the geographic impact of Eyad Abu‐Isa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyad Abu‐Isa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyad Abu‐Isa more than expected).

Fields of papers citing papers by Eyad Abu‐Isa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyad Abu‐Isa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyad Abu‐Isa. The network helps show where Eyad Abu‐Isa may publish in the future.

Co-authorship network of co-authors of Eyad Abu‐Isa

This figure shows the co-authorship network connecting the top 25 collaborators of Eyad Abu‐Isa. A scholar is included among the top collaborators of Eyad Abu‐Isa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyad Abu‐Isa. Eyad Abu‐Isa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 7
4 26
5 4
6 10
7 1
8 14
9 18
10 15
11 5
12 2
13 1
14 20
15 34
16 42
17 1
18 77
19 10
20 75

About Eyad Abu‐Isa

Eyad Abu‐Isa is a scholar working on Cancer Research, Oncology and Radiation, having authored 24 papers that have together received 404 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Prostate Cancer Treatment and Research (5 papers). The work is most often cited by research in Radiation (77 citations), Pulmonary and Respiratory Medicine (204 citations) and Oncology (126 citations). Eyad Abu‐Isa has collaborated with scholars based in United States, Brazil and Sweden. Frequent co-authors include Kent A. Griffith, Edgar Ben‐Josef, Theodore S. Lawrence, Alexander Lin, Mark M. Zalupski, Merav Ben‐David, James A. Knol, Daniel A. Hamstra, Howard M. Sandler and Sean Vance. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026